Galapagos NV DIO Ratio 2011-2026 | GLPG

Annual DIO Ratio Galapagos NV

2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	0.915	0.923	2.2	1.55	-

All numbers in EUR currency

Maximum	Minimum	Average
2.2	0.915	1.4

Issuer	DIO Ratio	Price	% 24h	Market Cap	Country
Ocular Therapeutix OCUL	183	$ 7.85	-2.73 %	$ 1.47 B	USA
Amphastar Pharmaceuticals AMPH	166	$ 19.59	0.31 %	$ 916 M	USA
Aeterna Zentaris AEZS	55.6	-	5.93 %	$ 314 M	Canada
Alexion Pharmaceuticals, Inc. ALXN	512	-	-	$ 40.3 B	USA
Albireo Pharma ALBO	26.1	-	-0.23 %	$ 916 M	USA
Midatech Pharma plc MTP	40.6	-	-18.52 %	$ 27.3 M	Britain
Arena Pharmaceuticals ARNA	160	-	-6.81 %	$ 3.04 B	USA
Acorda Therapeutics ACOR	345	-	-24.86 %	$ 820 K	USA
bluebird bio BLUE	125	-	-	$ 546 M	USA
Acasti Pharma ACST	136	-	4.01 %	$ 150 M	Canada
Институт стволовых клеток человека ISKJ	275	-	-	-	Russia
Pfizer PFE	244	$ 27.4	-0.63 %	$ 156 B	USA
Precigen PGEN	95.7	$ 3.83	-1.79 %	$ 1.2 B	USA
Avid Bioservices CDMO	102	-	-	$ 789 M	USA
BeiGene, Ltd. BGNE	304	-	0.49 %	$ 251 B	Cayman-islands
PTC Therapeutics PTCT	580	$ 66.68	-0.48 %	$ 5.3 B	USA
BioDelivery Sciences International BDSI	321	-	-4.8 %	$ 255 M	USA
Dr. Reddy's Laboratories Limited RDY	159	$ 13.61	-1.16 %	$ 2.26 B	India
Regeneron Pharmaceuticals REGN	661	$ 750.41	-0.84 %	$ 78.5 B	USA
Rigel Pharmaceuticals RIGL	163	$ 26.1	-1.02 %	$ 469 M	USA